Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Continuous arteriovenous hemofiltration in infants.

G Zobel1, A Beitzke, M Trop

  • 1Department of Pediatrics, University of Graz, Austria.

The International Journal of Pediatric Nephrology
|April 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A national equine identification and traceability system for emergency preparedness and response in New Zealand.

New Zealand veterinary journal·2025
Same author

Evaluating the immediate effects of hoof trimming on dairy goat hoof conformation and joint positions.

Veterinary research communications·2023
Same author

The Impact of SARS-COV-2 on two Colorectal Cancer screening centres.

Irish medical journal·2023
Same author

Evaluating the long-term conformation and hoof growth effects of starting hoof trimming at 5 months of age in New Zealand dairy goats.

Journal of dairy science·2022
Same author

Validation of Brix refractometers and a hydrometer for measuring the quality of caprine colostrum.

Journal of dairy science·2020
Same author

Short communication: Survival of replacement kids from birth to mating on commercial dairy goat farms in New Zealand.

Journal of dairy science·2019
Same journal

Type I primary hyperoxaluria associated with type I renal tubular acidosis.

The International journal of pediatric nephrology·1987
Same journal

Shunt nephritis with crescent formation.

The International journal of pediatric nephrology·1987
Same journal

Intraperitoneal bladder rupture in a battered child.

The International journal of pediatric nephrology·1987
Same journal

Acute glomerulonephritis secondary to lobar pneumonia.

The International journal of pediatric nephrology·1987
Same journal

Infantile nephronophthisis.

The International journal of pediatric nephrology·1987
Same journal

Growth disparity in monozygotic twins discordant for chronic renal disease.

The International journal of pediatric nephrology·1987
See all related articles

Continuous arteriovenous hemofiltration offers a viable renal replacement therapy for infants. This extracorporeal treatment effectively manages azotemia, hypervolemia, and toxic products in critically ill infants.

Area of Science:

  • Pediatric Nephrology
  • Critical Care Medicine
  • Extracorporeal Therapies

Background:

  • Infants with acute renal failure or metabolic disorders often require renal replacement therapy.
  • Hemodialysis and peritoneal dialysis present feasibility challenges in small infants.

Purpose of the Study:

  • To describe the technique and efficiency of continuous arteriovenous hemofiltration (CAVH) in small infants.
  • To evaluate CAVH as a renal replacement therapy option for pediatric patients.

Main Methods:

  • Continuous arteriovenous hemofiltration was utilized as the renal replacement therapy modality.
  • The technique involved spontaneous or suction-supported arteriovenous hemofiltration in five small infants.

Main Results:

Related Experiment Videos

  • CAVH effectively controlled azotemia and hypervolemia in anuric infants.
  • The therapy facilitated adequate parenteral nutrition and eliminated toxic products in amino acid disorders.
  • Continuous arteriovenous hemofiltration was well-tolerated by the infant population.

Conclusions:

  • Continuous arteriovenous hemofiltration is a feasible and effective renal replacement therapy for small infants.
  • This extracorporeal treatment can be implemented in pediatric intensive care units.
  • CAVH provides a crucial therapeutic option for infants with acute renal failure or metabolic issues.